Back to Search
Start Over
Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment.
- Source :
-
BMJ case reports [BMJ Case Rep] 2010 May 06; Vol. 2010. Date of Electronic Publication: 2010 May 06. - Publication Year :
- 2010
-
Abstract
- A case of solitary bone metastasis from breast cancer, where MRI assessment of treatment response was inaccurate and whole-body fluorodeoxyglucose ((18)FDG) positron emission tomography with computed tomography (PET-CT) proved more reliable and objective, is presented.
- Subjects :
- Aromatase Inhibitors therapeutic use
Bone Density Conservation Agents therapeutic use
Breast Neoplasms surgery
Diphosphonates therapeutic use
Disease Progression
Female
Fluorodeoxyglucose F18
Humans
Ibandronic Acid
Letrozole
Magnetic Resonance Imaging
Middle Aged
Nitriles therapeutic use
Radiopharmaceuticals
Spinal Neoplasms drug therapy
Triazoles therapeutic use
Breast Neoplasms pathology
Multimodal Imaging
Positron-Emission Tomography
Spinal Neoplasms diagnostic imaging
Spinal Neoplasms secondary
Tomography, X-Ray Computed
Subjects
Details
- Language :
- English
- ISSN :
- 1757-790X
- Volume :
- 2010
- Database :
- MEDLINE
- Journal :
- BMJ case reports
- Publication Type :
- Academic Journal
- Accession number :
- 22736731
- Full Text :
- https://doi.org/10.1136/bcr.11.2009.2457